Ionis Pharmaceuticals Inc. has announced that Dr. Richard Geary, executive vice president and chief development officer, will retire effective January 2026. Dr. Holly Kordasiewicz, currently the senior vice president of neurology, will succeed him in the role. Dr. Geary, who joined Ionis in 1995, will continue to serve as a strategic consultant throughout 2026 to ensure a seamless transition. Dr. Kordasiewicz, with 20 years of experience in research and development, has been with Ionis since 2011 and will lead the company's neurology program.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ionis Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250611030160) on June 12, 2025, and is solely responsible for the information contained therein.